Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Equity (2021 - 2026)

Journey Medical filings provide 5 years of Return on Equity readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2025 for Journey Medical, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.03% in Q3 2021 to a low of 0.1% in Q2 2023.
  • Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Equity: dropped -9bps in 2023 and later increased 11bps in 2024.
  • Journey Medical's Return on Equity stood at 0.03% in 2021, then surged by 53bps to 0.01% in 2022, then skyrocketed by 85bps to 0.0% in 2023, then plummeted by -362bps to 0.01% in 2024, then skyrocketed by 58bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.